New and Upcoming Activities

This week, PCSS-MOUD Clinical Expert Gregory Jaffe, MD will open his “office” to you.

Medical complications are common among patients who inject drugs. Signs and symptoms of acute or chronic infectious diseases often prompt patients to seek medical care. The time of presentation for complications related to injection drug use presents an opportunity to screen and employ early intervention strategies and engage individuals in addiction treatment. This course reviews features of skin and soft tissue infections among people who inject drugs, reviews risk factors for Hepatitis C (HCV) and HIV, describes prevention interventions for HCV and HIV, and discusses treatment approaches for HCV and HIV in patients with opioid use disorder.

This week, PCSS-MOUD Clinical Expert Kevin Sevarino, MD will open his “office” to you.

This activity reviews the following key data points which are important to primary care physicians: 1) the current epidemiologic data on drug-drug interactions between opioids and other medications, 2) possible explanations for increases in drug-drug interactions, 3) physiological and pharmacokinetic basis for adverse drug interactions, and 4) strategies for reducing risk for adverse drug interactions.

This webinar will outline the clinical reasoning, team-based strategies and patient-centered approaches that support engagement across the perinatal continuum, with an emphasis on MOUD management, mental health treatment, trauma-informed care and child welfare planning.